Michał Cholewiński

Recent advances in tyrosine kinase inhibitors VEGFR 1-3 for the treatment of advanced metastatic melanoma

P. Sobczuk, P. Rutkowski, Michał Cholewiński, 2024, Expert opinion on pharmacotherapy.